CLVS - Clovis Oncology - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $8.29. This is a potential upside of $8.29 (0%) from yesterday's end of day stock price of $0.

Clovis Oncology's activity chart (see below) currently has 128 price targets and 81 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 59.49% with an average time for these price targets to be met of 111.67 days.

Most recent stock forecast was given by EDWARD WHITE from HC WAINWRIGHT on 14-Jun-2022. First documented stock forecast 20-Jul-2015.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

2 years 6 months 7 days ago
(14-Jun-2022)

0/10 (0%)

$4.56 (102.70%)

Hold

$4.75

$4.66 (5177.78%)

$5.75

3 years 1 months 18 days ago
(03-Nov-2021)

10/12 (83.33%)

$0.06 (1.28%)

65

Sell

4 years 1 months 15 days ago
(06-Nov-2020)

3/5 (60%)

$5.73 (134.19%)

42

Buy

$16

$15.91 (17677.78%)

$17

4 years 4 months 14 days ago
(07-Aug-2020)

5/12 (41.67%)

$10.58 (195.20%)

77

Sell

$4

$3.91 (4344.44%)

$3

4 years 7 months 15 days ago
(06-May-2020)

3/5 (60%)

$-4.07 (-50.43%)

191

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CLVS (Clovis Oncology) average time for price targets to be met?

On average it took 111.67 days on average for the stock forecasts to be realized with a an average price target met ratio 59.49

Which analyst has the current highest performing score on CLVS (Clovis Oncology) with a proven track record?

MADHU KUMAR

Which analyst has the most public recommendations on CLVS (Clovis Oncology)?

Madhu Kumar works at GOLDMAN SACHS and has 8 price targets and 5 ratings on CLVS

Which analyst is the currently most bullish on CLVS (Clovis Oncology)?

Thomas Shrader with highest potential upside - $124.91

Which analyst is the currently most reserved on CLVS (Clovis Oncology)?

Charles Duncan with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?